Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in markets across emerging economies including India.
The generics business services the requirements of developed markets like US and Western Europe. Our API business sells products in over 65 countries including the US, various countries in the EU, South America and India.
With 14 manufacturing facilities and 4 R&D centers spanning across GPL and GLS, dedicated to the goal of enriching lives across the globe we believe that the real force behind our continued successes are dedicated employees from across 60 Nationalities, committed to creating ‘A new way for a new world’.
GLOBAL PHARMACEUTICAL COMPANY
We value knowledge such that it empowers our people to find innovative solutions to manage change
We respect all our stakeholders
We value achievement of objectives and consistently strive towards our Vision, with perseverance
Ranks among the World's Top 100 Biopharmaceuticals companies and 50 Generics and Biosimilars Companies
4 state-of-the-art R&D centres spanning across GPL and GLS.
Local offices in over 50 countries.
Over 15,000 dedicated employees worldwide, including 1400+ in R&D
14 manufacturing facilities spanning across GPL and GLS
Commercial presence in over 80 countries.